Targeted medicines are redefining modern healthcare by providing personalized therapies meticulously designed to address each patient’s unique disease profile. Given the early success of targeted medicines, such therapies hold great promise, but this often brings new complexities to navigate. Embark on a journey to master the complexities of targeted medicines in this white paper from Cencora PharmaLex.
This white paper presents considerations for planning, developing, and bringing to market targeted medicines with specific considerations for organizations to contemplate across key domains. Key Learning Objectives: